BIO International Convention Begins Day Two with Keynote from Pulitzer Prize-Winning Author Siddhartha Mukherjee

Author, physician and oncologist will discuss the history and
progress of
moving the science of genetics and cancer from the
lab to the real world

BIO International Convention
, the world’s premier life sciences
event, will open its second day in Philadelphia with a compelling
keynote address from Siddhartha Mukherjee, author of the Pulitzer
Prize-winning book, The Emperor of All Maladies: A Biography of Cancer
and New York Times Best Seller, The Gene: An Intimate History.

Today’s programming will also include compelling Super Sessions and
Fireside Chats with industry leaders, Start-up Stadium competition and a
BioGENEius award ceremony among other inspiring content.

Hosted by the Biotechnology Innovation Organization (BIO), the 2019 BIO
Convention will run through Thursday, June 6, at the Philadelphia
Convention Center, convening more than 16,000 attendees and 1,800
exhibitors from 67 countries.

Tuesday, June 4 Highlights Include:

  • Keynote: Siddhartha
    Mukherjee, Pulitzer Prize-winning author, physician and oncologist

    am | Ballroom AB

    • Siddhartha Mukherjee will be interviewed by BIO President and CEO
      Jim Greenwood about the unique challenges and opportunities for
      the biotech community in developing cures for cancer and genetic
    • PLEASE NOTE: Keynotes are open to Convention Access and
      Partnering Attendees. Seating is first-come, first-served.
  • Start-Up

    10:30 am – 1:00 pm & 2:00 – 4:30 pm |
    Exhibitor Hall, 3971

    Designed to provide start-up-level
    companies with the opportunity to engage key members of the investment
    community and venture philanthropy groups. BIO attendees can watch
    these impressive companies pitch their products to a panel of investor
  • BioGENEius
    Challenges Award Ceremony

    9:00–10:30 am | Ballroom AB
    BioGENEius Challenges provide high school students the opportunity to
    compete and be recognized for outstanding research in biotechnology.
  • Super Session: Realizing
    the Promise of Gene Therapies for Patients Around the World

    pm | 103ABC, Level 100

    Gene therapies are transforming
    patients’ lives in ways that were unimaginable twenty years ago. With
    recent scientific advances, commercial gene therapies have been met
    with exciting opportunities for treatment for previously untreatable
    genetic diseases. With these advances come challenges and
    opportunities in scientific discovery and new approaches in delivering
    drugs. Attend this Super Session to gain insights and perspectives
    from stakeholders with experience tackling these challenges while
    bringing new types of treatments to patients.
  • Fireside Chat: Understanding
    the Voices of Patients: Unique Perspectives on Healthcare

    am – 12:15 pm | 118B, Level 100

    This session will feature
    a conversation with patient advocates as they discuss their journeys
    to diagnosis and their viewpoints on our healthcare system. They will
    also share their perspectives on what it means to be a patient and how
    they are advocating in their own unique ways to achieve a common goal:
    bringing new treatments to patients.
  • Fireside Chat: Jeremy
    Levin, CEO, Chairman at Ovid Therapeutics interviews Jeffrey Solomon,
    Chief Executive Officer at COWEN

    11:00 am – 12:00 pm
    | 108A, Level 100
    A conversation with Jeffrey Solomon,
    former President, Chief Operating Officer and Head of Investment
    Banking at COWEN, a global financial services firm. Currently, Solomon
    is also a Director of NuGo Nutrition, the manufacturer of NuGo
    Nutrition Bars. Solomon is co-chair of the Equity Capital Formation
    Task Force, a group of individuals from across the country’s startup
    and small-capitalization company ecosystems advocating for market
    structure reform to encourage job creation and growth.
  • Fireside Chat: FDA
    Town Hall

    11:00 am – 12:15 pm | 113ABC, Level 100
    session will be an interactive, roundtable discussion of FDA
    priorities followed by a question-and-answer session with the
    audience. Topics will include the FDA’s perspectives on critical
    topics such as PDUFA VI implementation; efforts to advance innovation
    and expedite patient access to novel therapies for serious and
    life-threatening conditions; novel approaches to integrating new
    scientific tools into FDA regulatory practices at all levels; and FDA
    resources and scientific infrastructure.
  • Fireside Chat: Christi
    Shaw, Senior Vice President and President, Lilly BIO-Medicines, Eli
    Lilly and Company

    2:00-3:00 pm | 108A, Level 100
    Christi Shaw “More moments for more memories” isn’t just a mantra –
    it’s a personal and professional mission. She leads through the lens
    of innovation, integrity and inclusion and brings an unwavering
    commitment to addressing the evolving needs of patients, in
    collaboration with healthcare professionals, advocacy groups, payers
    and policy makers.

Follow the 2019 Convention @BIOConvention
and join the conversation @IAmBIOtech.

About BIO

BIO is the world’s largest trade association representing biotechnology
companies, academic institutions, state biotechnology centers and
related organizations across the United States and in more than 30 other
nations. BIO members are involved in the research and development of
innovative healthcare, agricultural, industrial and environmental
biotechnology products. BIO also produces the BIO
International Convention
, the world’s largest gathering of the
biotechnology industry, along with industry-leading investor and
partnering meetings held around the world. BIOtechNOW is
BIO’s blog chronicling “innovations transforming our world” and the BIO
Newsletter is the organization’s bi-weekly email newsletter. Subscribe
to the BIO Newsletter


Biotechnology Innovation Organization (BIO)
Theresa Brady

error: Content is protected !!